Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
2.290
-0.040 (-1.72%)
At close: Oct 15, 2026, 4:00 PM EDT
2.340
+0.050 (2.18%)
After-hours: Oct 15, 2026, 7:45 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $1.88 million as of October 15, 2026. It is the 48,144th most valuable company in the world and the 6,490th biggest in the United States. Its market cap has decreased by 77.92% in one year.
Market Cap
1.88M
Enterprise Value
-13.28M
1-Year Change
-77.92%
Global Rank
Country Rank
#6,490 United States
Category
ChartMarket Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.40M to $1.88M, a decrease of -83.53%. That is a compound annual growth rate of -19.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.88M | -53.07% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.00% |
| Dec 31, 2021 | 62.70M | -61.84% |
| Dec 31, 2020 | 164.30M | 3,121.57% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 45.61% |
| Mar 29, 2018 | 11.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 2.43M |
| PMGC Holdings | 2.40M |
| Propanc Biopharma | 2.32M |
| GeoVax Labs | 2.19M |
| Jaguar Health | 2.17M |
| Onconetix | 2.16M |
| SciSparc | 2.11M |
| Oragenics | 1.97M |